. Correlation of C-peptide Secretory Capacity during 2 nd phase of hyperglycemic clamp with mean fasting glycemia and coefficient of variation (CV) of fasting glycemia. Figure 2 . Functional beta-cell mass (FBM) as predictor of glycemic variability. Sensitivity and specificity of FBM for the prediction of coefficient of variation of fasting glycemia (CVfg). Shown are receiver-operating-characteristic curves and the corresponding areas under the curve. The area under the curve quantifies how well FBM correctly distinguishes a patient with a reduction to a CVfg < 25% from a patient with CVfg >25% (left panel) and a patient with a reduction by more than 50% of pretransplant CVfg from a patient without a reduction by more than 50% (right panel); the greater the area under the curve, the better the performance. 
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